aripiprazole has been researched along with ADDH in 37 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 11 (29.73) | 29.6817 |
2010's | 22 (59.46) | 24.3611 |
2020's | 4 (10.81) | 2.80 |
Authors | Studies |
---|---|
Lee, MC; Lin, JW; Tsai, LH | 1 |
Arango, C; Cabras, A; Cortese, S; Fusar-Poli, P; Hernández, P; Moreno, C; Parellada, M; Pastor Jordá, C; Salazar de Pablo, G; Santosh, P; Simonoff, E; Vaquerizo-Serrano, J; Veenstra-VanderWeele, J | 1 |
Campos, AC; Costa, KCM; Crippa, ACS; Crippa, JAS; Del-Bel, EA; Ferreira, FR; Guimarães, FS; Hallak, JEC; Lima, DA; Pedrazzi, JFC; Silva-Amaral, D; Zuardi, AW | 1 |
Fukuda, KI; Kasahara, S; Kato, Y; Matsudaira, K; Niwa, SI; Sato, N; Takahashi, K; Toyofuku, A; Uchida, K; Yoshikawa, T | 1 |
Han, TH; Kim, DY; Moon, JH; Park, DW | 1 |
Binici, NC; Güney, SA | 1 |
Abaei, A; Boeckers, TM; Fegert, JM; Hengerer, B; Nespoli, E; Rasche, V; Rizzo, F | 1 |
Naguy, A | 1 |
Anagnostou, E | 1 |
Fu, AT; Pan, PY; Yeh, CB | 1 |
Fujio, M; Hamamoto, Y; Kano, Y; Kono, T; Matsuda, N; Nonaka, M | 1 |
Ghanizadeh, A | 1 |
Alparslan, S; Eryilmaz, G; Isiten, N; Mutlu, C; Ozilhan, S; Saglam, E; Yorbik, O | 1 |
Párraga, HC; Sherman, BC | 1 |
Accordino, RE; Henry, CA; Kidd, C; McDougle, CJ; Politte, LC | 1 |
Alosi, N; Cucinotta, F; Di Rosa, G; Gagliano, A; Germanò, E; Italiano, D; Lamberti, M; Siracusano, R; Spina, E | 1 |
Bruhn, CH; Fink-Jensen, A; Jakobsen, KD; Nielsen, J; Pagsberg, AK | 1 |
Findling, RL | 1 |
Demeter, CA; Findling, RL; Leskovec, T; McNamara, NK; Short, EJ; Stansbrey, RJ; Townsend, LD | 1 |
Budman, C; Coffey, BJ; Schrock, M; Shechter, R; Simon, E; Spirgel, A; Wieland, N | 1 |
Ketzer, CR; Narvaez, J; Pheula, GF; Rohde, LA; Tramontina, S; Zeni, CP | 1 |
Ketzer, CR; Pheula, GF; Rohde, LA; Tramontina, S; Zeni, CP | 1 |
Carbray, MJ; McGuinness, T | 1 |
Barnett, RJ; Cauble, S; McLaren, JL | 1 |
Appel, DI; Markowitz, JS; Peterson, YK; Wang, Z; Zhu, HJ | 1 |
Chen, VC; Chou, JY; Robson, D; Yu, SH | 1 |
Carson, WH; Forbes, RA; Mankoski, R; Mathew, SJ; Zhao, J | 1 |
Calabrese, JR; Demeter, CA; Findling, RL; Frazier, TW; Lingler, J; McNamara, NK; Otto, BD; Rowles, BM; Stansbrey, RJ; Youngstrom, EA | 1 |
Cavanna, AE; Rickards, H; Worrall, R | 1 |
Berloffa, S; Calarese, T; Cedro, C; Gagliano, A; Ilardo, G; Magazù, A; Masi, G; Pfanner, C; Siracusano, R | 1 |
Coffey, DB; John, N; Potter, PO | 1 |
Stern, AP; Trieu, ML | 1 |
Aubry, JM; Bertschy, G; Bryois, C; Eliez, S; Etter, M; Nanzer, N | 1 |
Demb, H; Valicenti-McDermott, MR | 1 |
Aleardi, M; Biederman, J; Doyle, R; Hammerness, P; Joshi, G; Kotarski, M; Mick, E; Spencer, T; Wozniak, J | 1 |
de Souza, CK; Pheula, GF; Rohde, LA; Tramontina, S; Zeni, CP | 1 |
Kikukawa, S | 1 |
7 review(s) available for aripiprazole and ADDH
Article | Year |
---|---|
Systematic Review and Meta-analysis: Efficacy of Pharmacological Interventions for Irritability and Emotional Dysregulation in Autism Spectrum Disorder and Predictors of Response.
Topics: Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Humans; Risperidone | 2023 |
Cannabidiol for the treatment of autism spectrum disorder: hope or hype?
Topics: Aripiprazole; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Cannabidiol; Child, Preschool; Endocannabinoids; Humans | 2022 |
Clinical trials in autism spectrum disorder: evidence, challenges and future directions.
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Aggression; Antipsychotic Agents; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Central Nervous System Depressants; Central Nervous System Stimulants; Clinical Trials as Topic; Evidence-Based Medicine; Humans; Hypoglycemic Agents; Irritable Mood; Melatonin; Metformin; Methylphenidate; Obesity; Outcome Assessment, Health Care; Precision Medicine; Risperidone; Sleep; Sleep Wake Disorders | 2018 |
Systematic review of clinical trials of aripiprazole for treating attention deficit hyperactivity disorder.
Topics: Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Clinical Trials as Topic; Humans; Piperazines; Quinolones | 2013 |
Psychopharmacological interventions in autism spectrum disorder.
Topics: Aripiprazole; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Humans; Irritable Mood; Psychotropic Drugs; Risperidone; Stereotyped Behavior | 2016 |
Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Child; Dibenzothiazepines; Disorders of Excessive Somnolence; Headache; Humans; Methylphenidate; Obesity; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone | 2008 |
[Psychiatry].
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Humans; Lamotrigine; Mental Disorders; Methylphenidate; Piperazines; Quinolones; Risperidone; Triazines | 2005 |
10 trial(s) available for aripiprazole and ADDH
Article | Year |
---|---|
Aripiprazole/Methylphenidate Combination in Children and Adolescents with Disruptive Mood Dysregulation Disorder and Attention-Deficit/Hyperactivity Disorder: An Open-Label Study.
Topics: Adolescent; Antidepressive Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Comorbidity; Drug Therapy, Combination; Female; Humans; Male; Methylphenidate; Neuropsychological Tests | 2018 |
Head-to-Head Comparison of Aripiprazole and Risperidone in the Treatment of ADHD Symptoms in Children with Autistic Spectrum Disorder and ADHD: A Pilot, Open-Label, Randomized Controlled Study.
Topics: Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Child, Preschool; Female; Humans; Male; Pilot Projects; Risperidone | 2016 |
Aripiprazole in children with attention-deficit/hyperactivity disorder.
Topics: Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Child; Cognition; Dose-Response Relationship, Drug; Female; Headache; Humans; Male; Pilot Projects; Piperazines; Psychiatric Status Rating Scales; Quinolones; Severity of Illness Index; Treatment Outcome | 2008 |
Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/hyperactivity disorder: a pilot randomized clinical trial.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Child; Comorbidity; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Humans; Pilot Projects; Piperazines; Quinolones; Surveys and Questionnaires | 2009 |
Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder: a randomized crossover trial.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous System Stimulants; Child; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Methylphenidate; Piperazines; Psychiatric Status Rating Scales; Quinolones; Severity of Illness Index | 2009 |
Young mania rating scale line item analysis in pediatric subjects with bipolar I disorder treated with aripiprazole in a short-term, double-blind, randomized study.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Child; Comorbidity; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Inpatients; Male; Outpatients; Piperazines; Placebos; Psychiatric Status Rating Scales; Quinolones; Time Factors; Treatment Outcome | 2011 |
An open-label study of aripiprazole in children with a bipolar disorder.
Topics: Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous System Stimulants; Child; Child, Preschool; Comorbidity; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Outpatients; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome; Weight Gain | 2011 |
Aripiprazole in children with Tourette's disorder and co-morbid attention-deficit/hyperactivity disorder: a 12-week, open-label, preliminary study.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Child; Female; Humans; Logistic Models; Male; Obsessive-Compulsive Disorder; Piperazines; Quinolones; Severity of Illness Index; Tourette Syndrome; Treatment Outcome | 2012 |
An open-label trial of aripiprazole monotherapy in children and adolescents with bipolar disorder.
Topics: Adolescent; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Brief Psychiatric Rating Scale; Child; Drug Tolerance; Female; Humans; Male; Piperazines; Quinolones; Surveys and Questionnaires | 2007 |
Aripiprazole in juvenile bipolar disorder comorbid with attention-deficit/hyperactivity disorder: an open clinical trial.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Child; Double-Blind Method; Female; Humans; Male; Piperazines; Quinolones | 2007 |
20 other study(ies) available for aripiprazole and ADDH
Article | Year |
---|---|
Social Communication Disorder in an Adolescent with ADHD and Tourette's Disorder Treated with Aripiprazole.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Humans; Social Communication Disorder; Tourette Syndrome | 2022 |
Diagnosis and treatment of intractable idiopathic orofacial pain with attention-deficit/hyperactivity disorder.
Topics: Aripiprazole; Attention Deficit Disorder with Hyperactivity; Chronic Pain; Facial Pain; Humans; Retrospective Studies | 2023 |
Transient Isolated Lower Bulbar Palsy With Elevated Serum Anti-GM1 and Anti-GD1b Antibodies During Aripiprazole Treatment.
Topics: Aripiprazole; Attention Deficit Disorder with Hyperactivity; Bulbar Palsy, Progressive; Child; G(M1) Ganglioside; Gangliosides; Humans; Immunoglobulin G; Male; Psychotropic Drugs | 2017 |
Epistaxis as an Unexpected Side Effect of Aripiprazole and Risperidone Treatment in Two Children with Two Different Psychiatric Diagnosis.
Topics: Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Child, Preschool; Epistaxis; Humans; Male; Mood Disorders; Risperidone | 2017 |
Aripiprazole and Riluzole treatment alters behavior and neurometabolites in young ADHD rats: a longitudinal
Topics: Animals; Antipsychotic Agents; Aripiprazole; Aspartic Acid; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Brain; Disease Models, Animal; Glutamic Acid; Magnetic Resonance Spectroscopy; Male; Motor Activity; Neuroprotective Agents; Rats; Rats, Inbred WKY; Riluzole | 2017 |
Pharmacotherapy of Attention Deficit Hyperactivity Disorder Symptom Profile in ASD.
Topics: Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Comorbidity; Cross-Sectional Studies; Guanfacine; Humans; Methylphenidate; Randomized Controlled Trials as Topic; Risperidone; Social Adjustment; Treatment Outcome | 2017 |
Expert consensus on pharmacotherapy for tic disorders in Japan.
Topics: Adult; Aged; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Comorbidity; Consensus; Drug Therapy; Expert Testimony; Female; Health Knowledge, Attitudes, Practice; Humans; Japan; Male; Middle Aged; Physicians; Risperidone; Surveys and Questionnaires; Tic Disorders; Tics; Tourette Syndrome | 2019 |
Plasma Methylphenidate Levels in Youths With Attention Deficit Hyperactivity Disorder Treated With OROS Formulation.
Topics: Administration, Oral; Adolescent; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Interactions; Female; Fluoxetine; Humans; Male; Methylphenidate; Retrospective Studies; Risperidone; Sertraline | 2015 |
Acute Dystonia After Stimulant Discontinuation in 2 ADHD Children Receiving Aripiprazole.
Topics: Aripiprazole; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dystonia; Female; Humans; Male; Withholding Treatment | 2015 |
Neurological, Metabolic, and Psychiatric Adverse Events in Children and Adolescents Treated With Aripiprazole.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Child, Preschool; Databases, Factual; Denmark; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Neurodevelopmental Disorders; Obsessive-Compulsive Disorder; Psychotic Disorders; Schizophrenia; Tourette Syndrome | 2016 |
Aripiprazole in children and adolescents with Tourette disorder with and without explosive outbursts.
Topics: Adolescent; Aggression; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Child; Child Behavior Disorders; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Obsessive-Compulsive Disorder; Piperazines; Psychiatric Status Rating Scales; Quinolones; Retrospective Studies; Severity of Illness Index; Tourette Syndrome; Treatment Outcome | 2008 |
Pediatric bipolar disorder.
Topics: Adolescent; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Child; Child Psychiatry; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Diagnostic and Statistical Manual of Mental Disorders; Humans; Lithium Carbonate; Nursing Assessment; Parents; Patient Education as Topic; Piperazines; Psychiatric Nursing; Psychotherapy; Quinolones; Risperidone; Social Support | 2009 |
Aripiprazole induced acute dystonia after discontinuation of a stimulant medication.
Topics: Acute Disease; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous System Stimulants; Child; Drug Administration Schedule; Dystonia; Humans; Male; Methylphenidate; Piperazines; Quinolones; Substance Withdrawal Syndrome | 2010 |
Identification of selected therapeutic agents as inhibitors of carboxylesterase 1: potential sources of metabolic drug interactions.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Carboxylic Ester Hydrolases; Central Nervous System Stimulants; Cluster Analysis; Drug Evaluation, Preclinical; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Humans; Hydrolysis; Inactivation, Metabolic; Male; Methylphenidate; Mice; Models, Molecular; Piperazines; Quinolones | 2010 |
Aripiprazole for the tic symptoms in a child receiving atomoxetine treatment for ADHD.
Topics: Adrenergic Uptake Inhibitors; Antipsychotic Agents; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Humans; Male; Piperazines; Propylamines; Quinolones; Tic Disorders | 2010 |
Treatment practices in Tourette syndrome: the European perspective.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Depression; Europe; Fluoxetine; Fluvoxamine; Health Care Surveys; Humans; Methylphenidate; Obsessive-Compulsive Disorder; Physicians; Piperazines; Propylamines; Psychiatry; Quinolones; Risperidone; Sertraline; Sulpiride; Tourette Syndrome | 2012 |
Onset of abnormal movements and cardiovascular symptoms after acute change in complex polypharmacy in a child with attention-deficit/hyperactivity disorder and mood symptoms.
Topics: Adrenergic alpha-Agonists; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Asthma; Attention Deficit Disorder with Hyperactivity; Cardiovascular Diseases; Chest Pain; Child; Dyskinesia, Drug-Induced; Family; Female; Guanfacine; Humans; Lithium Chloride; Male; Mood Disorders; Neuropsychological Tests; Obesity; Paroxetine; Piperazines; Polypharmacy; Pregnancy; Prenatal Exposure Delayed Effects; Psychomotor Agitation; Quinolones; Selective Serotonin Reuptake Inhibitors; Smoking; Social Environment | 2012 |
A case of antipsychotic-induced hyperglycemia in a child with insulin dependent diabetes mellitus.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Blood Glucose; Diabetes Mellitus, Type 1; Hospitalization; Humans; Hyperglycemia; Language Disorders; Learning Disabilities; Male; Piperazines; Quinolones; Risperidone | 2012 |
Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities.
Topics: Adolescent; Aggression; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Body Mass Index; Child; Child Behavior Disorders; Child, Preschool; Dose-Response Relationship, Drug; Drug Approval; Female; Follow-Up Studies; Humans; Impulsive Behavior; Intellectual Disability; Male; Mood Disorders; Piperazines; Quinolones; Reactive Attachment Disorder; Self-Injurious Behavior; Sleep Wake Disorders | 2006 |
Effectiveness of aripiprazole in treatment of adults with attention deficit disorder and restless legs syndrome.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Female; Humans; Piperazines; Quinolones; Restless Legs Syndrome | 2008 |